0001209191-21-071241.txt : 20211227
0001209191-21-071241.hdr.sgml : 20211227
20211227161115
ACCESSION NUMBER: 0001209191-21-071241
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211223
FILED AS OF DATE: 20211227
DATE AS OF CHANGE: 20211227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIXON WENDY L
CENTRAL INDEX KEY: 0001202283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 211520568
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-23
0
0000879169
INCYTE CORP
INCY
0001202283
DIXON WENDY L
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
1
0
0
0
Common Stock
2021-12-23
4
M
0
20000
73.25
A
37259
D
Common Stock
2021-12-23
4
S
0
20000
22.05
D
17259
D
Non Qualfied Stock Option (right to buy)
73.25
2021-12-23
4
M
0
20000
0.00
D
2022-05-29
Common Stock
20000
0
D
Represents weighted average sale price. Actual sale prices ranged from $73.01 - $73.54. Reporting person undertakes to provide upon request
by Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of
shares sold within range indicated.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning May 30, 2012, options become exercisable in full on May 30, 2013.
/s/ Maria Pasquale, Attorney-In-Fact
2021-12-27